Fibrinogen Screen
System, Fibrinogen Determination. 510(k) K800826, from Pacific Hemostasis (Mchenry, IL). Product code KQJ, class 2.
As of Nov 20, 2026, K800826 is an FDA 510(k) held by Pacific Hemostasis, substantially equivalent on May 30, 1980 after 46 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 46 days
- Recalls: 2
- Cited as a predicate by: 1 device
- Stasis - I, Ii and Iii; Serathan - A, B; Intrin - Ea, Si Calcium Chloride 0.02M; Fibrinogen Control-Normal, LowK060968 · Wortham Laboratories, Inc. · May 15, 2007
| Started | Recall | Status |
|---|---|---|
| May 19, 2017 | Z-2763-2017, Z-2762-2017An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP… | Terminated |
- HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XLK251968 · Instrumentation Laboratory (IL) Co. · Jul 24, 2025
- Type
- Traditional
- Received
- Apr 14, 1980
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7340
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files